Evidence map›Paper›PMID 27583246›Full record

ArticleFrontiers in cell and developmental biology2016

Corrigendum: Personalized Medicine Approaches in Prostate Cancer Employing Patient Derived 3D Organoids and Humanized Mice.

Monica Bartucci, Anna C Ferrari, Isaac Yi Kim, Alexander Ploss, Martin Yarmush, Hatem E Sabaawy

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 31 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Monica BartucciRutgers Cancer Institute of New Jersey, Rutgers University New Brunswick, NJ, USA.
Anna C FerrariRutgers Cancer Institute of New Jersey, Rutgers University New Brunswick, NJ, USA.
Isaac Yi KimRutgers Cancer Institute of New Jersey, Rutgers University New Brunswick, NJ, USA.
Alexander PlossRutgers Cancer Institute of New Jersey, Rutgers UniversityNew Brunswick, NJ, USA; Department of Molecular Biology, Princeton UniversityPrinceton, NJ, USA.
Martin YarmushCenter for Engineering in Medicine, Shriners Hospitals for Children and Department of Surgery, Massachusetts General Hospital, Harvard Medical SchoolBoston, MA, USA; Department of Biomedical Engineering, Rutgers UniversityNew Brunswick, NJ, USA.
Hatem E SabaawyRutgers Cancer Institute of New Jersey, Rutgers UniversityNew Brunswick, NJ, USA; Department of Medicine, Rutgers Biomedical and Health Sciences (RBHS)-Robert Wood Johnson Medical School, Rutgers UniversityNew Brunswick, NJ, USA.
Rutgers, The State University of New Jersey · USJohnson University · USShriners Hospitals for Children - Erie · US

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
NCI NIH HHS P30 CA072720
6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fcell.2016.00064.].

Indexed as

organoidsprecision medicineprecision therapeuticsprostate cancer

Identifiers

PMID27583246
PMCPMC4999522
OpenAlexW2472832969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.